RAS/BRAF testing of circulating cell-free DNA (cfDNA) in RAS/BRAF wild-type (RAS/BRAF ^WT ) metastatic colorectal cancer (mCRC) patients: Preliminary results of the phase III LIBImAb study.

Anna Maria Rachiglio, Carmine Pinto, Cecilia Silvestri et al.|Journal of Clinical Oncology|2025

Cited by 1